BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
Abstract Sustained expression of programmed cell death receptor-1 (PD-1) is correlated with the exhaustion of T cells, and blockade of the PD-1 pathway is an effective immunotherapeutic strategy for treating various cancers. However, response rates are limited, and many patients do not achieve durab...
Main Authors: | Mengjun Zhong, Rili Gao, Ruocong Zhao, Youxue Huang, Cunte Chen, Kehan Li, Xibao Yu, Dingrui Nie, Zheng Chen, Xin Liu, Zhuandi Liu, Shaohua Chen, Yuhong Lu, Zhi Yu, Liang Wang, Peng Li, Chengwu Zeng, Yangqiu Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-08-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-05123-x |
Similar Items
-
Correction to: BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia
by: Mengjun Zhong, et al.
Published: (2022-08-01) -
High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia
by: Xibao Yu, et al.
Published: (2023-04-01) -
Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis
by: Dingrui Nie, et al.
Published: (2022-07-01) -
Selective inhibition of BET bromodomains.
by: Filippakopoulos, P, et al.
Published: (2010) -
Selective inhibition of BET bromodomains.
by: Filippakopoulos, P, et al.
Published: (2010)